WallStreetZenWallStreetZen

NASDAQ: RNTX
Rein Therapeutics Inc Stock Ownership - Who owns Rein Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rein Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James Brian WindsorPresident and CEO2024-12-05161$2.25
$362.25Buy
James Brian WindsorPresident and CEO2024-12-05239$2.24
$535.36Buy
University Of Texastexas Am Investment Management Co10% Owner2024-06-174,707$3.25
$15.30kSell
University Of Texastexas Am Investment Management Co10% Owner2024-06-141,900$3.30
$6.27kSell
University Of Texastexas Am Investment Management Co10% Owner2024-06-121$3.28
$3.28Sell
University Of Texastexas Am Investment Management Co10% Owner2024-06-129,341$3.25
$30.36kSell
University Of Texastexas Am Investment Management Co10% Owner2024-06-115,250$3.25
$17.06kSell
University Of Texastexas Am Investment Management Co10% Owner2024-06-11502$3.35
$1.68kSell
University Of Texastexas Am Investment Management Co10% Owner2024-06-109,577$3.30
$31.60kSell
University Of Texastexas Am Investment Management Co10% Owner2024-06-071,564$3.25
$5.08kSell

1 of 6

RNTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RNTX insiders and whales buy or sell their stock.

RNTX Shareholders

What type of owners hold Rein Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Muneer A. Satter75.52%16,609,449$28.24MInsider
Reinhard J. Ambros11.59%2,549,982$4.33MInsider
Novartis Bioventures Ltd9.46%2,079,394$3.53MInsider
Of Texastexas Am Investment Managment Co University8.23%1,810,457$3.08MInsider
University Of Texastexas Am Investment Management Co7.94%1,746,549$2.97MInsider
Bios Capital Management LP7.69%1,690,751$2.87MInstitution
Brian M. Gallagher Jr.6.51%1,431,519$2.43MInsider
Armen Shanafelt4.98%1,094,987$1.86MInsider
LV Management Group LLC4.98%1,094,987$1.86MInsider
Excel Medical Fund LP4.62%1,016,100$1.73MInsider

1 of 3

RNTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RNTX14.37%85.63%Net Selling
ANEB41.27%58.73%Net Buying
CLLS45.57%0.00%
OKYO0.19%99.81%
CAMP42.83%57.17%Net Buying
View Top Biotech Stocks

Rein Therapeutics Stock Ownership FAQ

Who owns Rein Therapeutics?

Rein Therapeutics (NASDAQ: RNTX) is owned by 25.82% institutional shareholders, 153.92% Rein Therapeutics insiders, and 0.00% retail investors. Muneer A. Satter is the largest individual Rein Therapeutics shareholder, owning 16.61M shares representing 75.52% of the company. Muneer A. Satter's Rein Therapeutics shares are currently valued at $29.56M.

If you're new to stock investing, here's how to buy Rein Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.